Introduction
Because Ca 2ϩ has roles in mechanoelectric transduction, cochlear amplification, and synaptic function (Zhang et al., 2003; Stepanyan and Frolenkov 2009; Pangršič et al., 2015) , the regulation and control of Ca 2ϩ is a major challenge for cochlear hair cells. The mammalian cochlea has two types of hair cells involved in the transduction of sound into electrical responses. Outer hair cells (OHCs) amplify vibrations of the cochlear partition directly enhancing sensitivity and frequency selectivity, whereas the inner hair cells (IHCs) release glutamate from ribbon synapses directly exciting the endings of auditory nerve fibers responsible for transmitting sound information to the brain. The OHCs are prominent targets of noise and aging and, when damaged, lead to elevated hearing thresholds and loss of cochlear frequency tuning.
To control Ca 2ϩ levels in hair cells, a multitude of proteins act as buffers, sensors, or pumps. Although previous studies show that the free Ca 2ϩ concentration in OHCs rises after acoustic overstimulation (Fridberger et al., 1998) , there are few studies that link Ca 2ϩ homeostasis directly with hearing loss (Mammano 2011) . In hair cells, mobile EF-hand Ca 2ϩ -binding proteins or "buffers" may play a significant role in Ca 2ϩ homeostasis and signaling. These proteins are characterized by a common sequence of ϳ30 residues forming a helix-loop-helix motif, which, when bound to Ca 2ϩ , causes a conformational change, allowing for interaction with downstream proteins (Lewit-Bentley and Réty 2000) . Although most EF-hand Ca 2ϩ buffers are found extensively throughout the nervous system, oncomodulin (Ocm), an isoform of ␣-parvalbumin originally discovered in a rat hepatoma (MacManus et al., 1983) , is limited to OHCs and also found in macrophages (Thalmann et al., 1998; Yang et al., 2004; Yin et al., 2009 ). In the inner ear, mobile EF-hand Ca 2ϩ buffers have been difficult to study, because their expression levels change during maturation (Pack and Slepecky 1995; Sage et al., 2000) . For example, ␣-parvalbumin, calretinin, and calbindin-D28k are expressed in both IHCs and OHCs at birth and are all downregulated in OHCs, whereas Ocm is upregulated before the onset of hearing (Pack and Slepecky 1995; Yang et al., 2004; Simmons et al., 2010) . In OHCs, the possible replacement of multiple Ca 2ϩ buffers by a single one, Ocm, suggests its functional specificity in OHCs. Estimates from immunogold studies suggest that Ocm levels may be as high as 4 -6 mM in OHCs (Hackney et al., 2005) . In the mouse ear, Ocm is preferentially localized to subcellular compartments associated with Ca 2ϩ -dependent motility processes, i.e., along the sides of the OHCs, above the synaptic zone, and below the cuticular plate in which the stereocilia insert (Simmons et al., 2010) . Given that Ocm is a member of the parvalbumin family, is subcellularly compartmentalized, and is prominent in OHCs to the exclusion of other EF-hand Ca 2ϩ buffers, its role in the regulation of Ca 2ϩ may be critically important to OHC function (Hackney et al., 2005; Simmons et al., 2010) .
To test our ideas about the importance of OHC Ca 2ϩ buffering in general, and Ocm specifically, we engineered a targeted deletion of Ocm. Previous studies of genetic disruption of ␣-parvalbumin, calbindin-D28k, and calretinin have not reported any inner ear phenotype for either individual or combined knock-outs of these EFhand Ca 2ϩ buffers (Airaksinen et al., 2000; Pangršič et al., 2015) .
Materials and Methods
All experiments were done in compliance with National Institutes of Health and institutional animal care guidelines and were approved by the following institutional animal care and use committees: University of California, Los Angeles, Massachusetts Eye and Ear Infirmary, and Washington University School of Medicine. Generation of Ocm mutant mice. The coding sequence for mouse Ocm is contained in five exons on chromosome 5 (Staubli et al., 1995) . Seventeen kilobases of the Ocm gene containing exons 2-4 were cloned into pBSKS from BAC DNA. As illustrated in Figure 1A , a LoxP site was engineered 5Ј of exon 2, and an Flp-neo-Flp-LoxP cassette was engineered 3Ј of exon 4. After sequencing of the exon junctions, the 5Ј LoxP site and the 3Јcassette, the vector was electroporated into ES cells (SSC#10, 129sv), and clones resistant to G418 were isolated (electroporation and selection of resistant clones was done at the Washington University Embryonic Stem Cell Core) and checked for homologous recombination by Southern blot analysis. Positive clones were karyotyped. Two male clones were injected into C57BL/6J blastocysts. High percentage chimeras were crossed with CBA/CaJ mice, and the pups were checked for germ-line transmission. Initial confirmation of germ-line transmission was done by Southern blot analysis. Subsequently, PCR primers used for genotyping were made from the deleted region (5Ј-CTC CAC ACT TCA CCA AGC AG-3Ј and 5Ј-GCT TGG GGA CCC CCT GTC TTC A-3Ј) and from the targeting vector (5Ј-CTC CAC ACT TCA CCA AGC AG-3Ј and 5Ј-TTT CAT GTT CAG GGA TCA AGT G-3Ј). The neo gene was removed when generating the Ocm heterozygote to avoid any possible interference (Wassarman et al., 1997 For in vivo functional assays, mice were anesthetized with ketamine (100 mg/kg, i.p.) and xylazine (10 mg/ kg, i.p.) and were maintained at a body temperature of 37°C during testing. Auditory brainstem responses (ABRs) and distortion product otoacoustic emissions (DPOAEs) were measured as described previously (Ohlemiller et al., 2011; Maison et al., 2012) . For histological analysis and immunocytochemistry, anesthetized mice were perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate buffer. Cochleae were prepared as cochlear whole mounts or mid-modiolar sections as described previously (Simmons et al., 2010; Maison et al., 2012) . For whole mounts, each cochlea was microdissected and immunostained with antibodies to myosin VIIa (1:200, rabbit polyclonal; Proteus Biosciences) and appropriate secondary antibodies. Whole mounts were further stained with phalloidin. For mid-modiolar sections, cochleae were embedded in a gelatin-agarose solution, and 200 m vibratomed sections were taken and immunostained with antibodies to ␣-parvalbumin (1: 2000, goat polyclonal; PVG-214; Swant) or calretinin (1:500, goat polyclonal; CG1; Swant) and prestin (1:1000, rabbit polyclonal; kind gift from R. Fettiplace, University of Wisconsin, Madison, WI). Confocal z-stacks of specific frequency regions from each ear were obtained (LSM5; Zeiss) using a high-resolution, water-immersion objective (C-Apochromat 63ϫ, 1.20 numerical aperture). For whole mounts, each stack spanned 80 -100 m of cochlear length and two adjacent stacks were imaged at each locus. Image stacks were processed using Volocity software (Improvision, 4.x; PerkinElmer Life and Analytical Sciences).
Results
To test our hypothesis that Ocm plays a pivotal role in OHC function, we created a mutant mouse in which the Ocm gene was targeted for deletion. Our targeting strategy removed exons 2-4 of the Ocm gene (Fig. 1A) . Exons 3 and 4 contain two Ca 2ϩ binding motifs (Henzl et al., 2000) , and exon 2 contains the N terminus of Ocm. Germ-line transmission was confirmed initially by Southern blot analysis (Fig. 1B) and then subsequently by a multistep PCR scheme involving both a 5Ј Lox P site and a 3Ј cassette and/or 3Ј LoxP site. Crossing the Ocm flox/flox mice to mice with ␤-actin-Cre-driven promoter expression generated Actb . For immunoreactivity, we tested both a monoclonal mouse anti-Ocm and a polyclonal rabbit anti-Ocm, both of which were raised against recombinant full-length Ocm (Simmons et al., 2010) . In age-matched controls, the Ocm antisera labeled OHCs throughout the cochlear spiral as expected. There was no Ocm labeling in tissues from Ocm Ϫ/Ϫ mutants with either antibody (Fig. 1C,D) . Although IHCs routinely labeled for ␣-parvalbumin (Fig. 1C,D) and calretinin (data not shown) in adult Ocm Ϫ/Ϫ mutants and wild-type controls, there was no labeling of either protein in Ocm Ϫ/Ϫ OHCs from basal locations, suggesting that expression was not altered for either of these Ca 2ϩ buffers. Furthermore, Ocm Ϫ/Ϫ mutants show normal developmental expression of ␣-parvalbumin and hair bundles in IHCs and OHCs from postnatal day (P) 4 (Fig. 1E) up to 4 weeks. None of the Ocm Ϫ/Ϫ mutants had any obvious behavioral or developmental abnormalities and no difference in body weights compared with wild-type littermates.
To test cochlear function, we measured ABRs in anesthetized adult mice between aged 14 -26 weeks using seven test frequencies (5.6, 8, 11.3, 16, 22.4, 32, and 45.2 kHz) . As shown in Figure  1F , average ABR wave responses to a 16 kHz tone at the highest sound pressure level (80 dB SPL) are similar for wild-type and heterozygous mice but absent for Ocm Ϫ/Ϫ mice. In wild-type mice, ABR thresholds vary with frequency from a sound pressure level as low as 35 dB at 11.3 kHz to as high as 65 dB at 45.6 kHz (Fig. 1G) . Ocm Ϫ/Ϫ mutants were profoundly hearing impaired at this young-adult age, with ABR thresholds 20 -50 dB higher than those in wild-type mice, corresponding to what would be considered a moderate-to-severe hearing loss in humans. In Ocm Ϫ/Ϫ mutants, the lowest measurable ABR thresholds were at the lowest test frequencies: 77.8 dB SPL at 5.7 kHz and 82.8 dB SPL at 8 kHz. Heterozygous mice show ABR thresholds similar to their wild-type counterparts; the small differences in the mean values were not statistically significant ( p ϭ 0.20 by two-way ANOVA).
To assess OHC function in vivo, we measured DPOAEs, the electromechanical distortions in response to two primary tones ( f 1 and f 2 ) that are amplified by OHCs and propagated back through the middle ear. In the Ocm Ϫ/Ϫ mutant at 14 -26 weeks, DPOAE thresholds were at or near the measurement ceiling for all test frequencies (Fig. 1H ) , consistent with a defective OHC or cochlear amplification system (Mills 2006). These results suggest that the expression of Ocm is critical for cochlear function. We also investigated the onset of cochlear dysfunction in Ocm Ϫ/Ϫ mutants. Figure 1I shows ABR thresholds for Ocm Ϫ/Ϫ mutants and wild types at two different ages using five test frequencies: 5, 10, 20, 28.3, and 40 kHz. At 4 weeks, 2 weeks after hearing onset, ABR thresholds were similar between the two genotypes (Fig. 1I) . The slight differences at middle frequencies were not statistically significant (p ϭ 0.11 by two-way ANOVA). However, by 12 weeks, Ocm Ϫ/Ϫ mutants showed elevated ABR thresholds above 10 kHz when compared with 4 weeks. The differences in threshold responses between 4 and 12 weeks were replotted as threshold shifts (Fig. 1J) . In Ocm Ϫ/Ϫ mutants, threshold shifts ranged from as little as 6 dB at 5 kHz to as much as 60 dB at 20 kHz. In contrast, wild types at 12 weeks showed little change from 4 weeks.
In Ocm Ϫ/Ϫ mutants up to 8 weeks, OHC morphology and prestin-IR (data not shown) were normal with minimal hair cell loss throughout the cochlear spiral (Fig. 1K,L) . However, after 12 weeks, Ocm Ϫ/Ϫ mutants showed greater scattered OHC loss and scattered loss of pillar cells (Fig. 1N,P) , especially in higher-frequency regions compared with wild-type controls (Fig. 1M,O) . In Ocm Ϫ/Ϫ mutants, OHC loss was spotty, with alternating regions of intact and missing cells. The degree of loss was variable across animals but generally greatest in rows 1 and 2 and least in row 3. IHC loss was minimal but significantly different from control at 12 weeks in the extreme base of the cochlea. These results suggest that Ocm may have a modulatory effect on the mechanoelectric transduction or prestin-driven electromotive processes. Because we could find no obvious differences in phalloidinstained bundles between wild-type and Ocm Ϫ/Ϫ mutant OHCs at 3 months, we compared prestin-IR in wild types (Fig. 1Q) and Ocm Ϫ/Ϫ mutants (Fig. 1R) . At 2 months, there were no obvious differences in prestin-IR between wild-type controls and Ocm Ϫ/Ϫ mutant mice. However, at 3 months, unlike wildtype control OHCs, prestin-labeled Ocm Ϫ/Ϫ OHCs from middle-frequency regions appear shorter and more intensely labeled, suggesting that Ocm and/or Ca 2ϩ buffering help maintain normal prestin expression patterns.
Discussion
In the present study, we assessed the role of Ocm, an EF-hand Ca 2ϩ -binding protein predominately expressed in OHCs in the mammalian cochlea. We generated a conditional knock-out line using Cre-recombinase driven by the ␤-actin promoter (Actb Cre ; Ocm flox/flox ). Using this targeted deletion of Ocm, we show that lack of this Ca 2ϩ buffer leads to progressive cochlear dysfunction beginning after 1 month and results in ABR threshold shifts and loss of DPOAEs by 4 months of age. Functionally, the absence of Ocm mimics an accelerated aging or noise damage process. The presence of normal ABR and DPOAE thresholds in Ocm Ϫ/Ϫ mutants at 1 month shows that Ocm is not essential for the development of cochlear function. However, the progressive hearing loss after 1 month suggests that Ocm expression critically protects OHCs from damage in the mature ear.
In hair cells, Ca 2ϩ is both a primary and a secondary messenger. Calcium serves as a primary ion for at least four different channel types found in OHCs (Sziklai 2004; Fettiplace 2006) . Calcium can also be released from the subsurface cisternae and mitochondria in an IP 3 -dependent manner (Frolenkov et al., 2000; Szönyi et al., 2001) . Calcium entering through nicotinic receptors acts as a second messenger by binding the SK2 channel, which results in an outflow of potassium (Oliver et al., 2000; Marcotti et al., 2004) . Calcium can also bind to calmodulin activating many calmodulin-dependent pathways (Sziklai et al., 2001; Farahbakhsh and Narins 2006) . Ca 2ϩ buffers play an important role in regulating intracellular Ca 2ϩ concentration, and excess Ca 2ϩ can lead to cell death (Rizzuto et al., 2003) . Given the presumed importance of EF-hand Ca 2ϩ -binding proteins such as ␣-parvalbumin, calbindin-D28k, and calretinin in hair cells, genetic disruption of these Ca 2ϩ buffers should affect auditory function. However, a recent study of a triple knockout of these EF-hand mobile buffers found that there was little or no loss of hearing in 12-16 week old mutants (Pangršič et al., 2015) , suggesting that hair cells have strong compensatory mechanisms to regulate Ca 2ϩ at least up through the ages tested. Because the onset of Ocm expression coincides with a decline in the expression of other EF-hand Ca 2ϩ buffers in OHCs, the loss of Ocm might lead to upregulation of these Ca 2ϩ buffers. However, previous studies of genetic disruption of EF-hand Ca 2ϩ buffers suggest that each Ca 2ϩ buffer has distinct properties and that their absence in knock-out mice cannot be simply substituted by another EF-hand family member (Chen et al., 2006; . For example, in ␣-parvalbumin-deficient mice, the major compensatory changes observed are altered dendritic morphology and changes in mitochondria size and location but not changes in expression of other EF-hand Ca 2ϩ buffers . Consistent with this idea, we did not find any changes in the immunoreactivity of other EF-hand Ca 2ϩ buffers in OHCs. We know that Ca 2ϩ levels in hair cells can be regulated by pumps, such as by the plasma membrane Ca 2ϩ ATPase (PMCA), Na ϩ /Ca 2ϩ exchanger (NCX), sarcoplasmic/endoplasmic reticulum Ca 2ϩ ATPase (SERCA), and by a uniporter into mitochondria (Sziklai 2004) . Thus, the lack of EF-hand Ca 2ϩ buffers may be compensated for by increased mitochondrial Ca 2ϩ uptake or increased PMCA activity. However, none of these were sufficient to compensate for the loss of Ocm, suggesting a functionally distinctive role.
In OHCs, Ocm may have a dual role as a Ca 2ϩ buffer and sensor similar to suggested roles for calmodulin (Figure legend continued.) mutant cochlea shows no Ocm (green) or ␣-parvalbumin (red) immunolabeling in OHCs. IHCs do show immunoreactivity for ␣-parvalbumin (red). E, Basal turn section from an Ocm Ϫ/Ϫ mutant at P4. ␣-Parvalbumin (red) labels both IHCs and OHCs. Phalloidin (cyan) staining is also shown. F, Averaged ABR wave responses from adult (14 -26 weeks) wild-type (n ϭ 3), heterozygous (n ϭ 6), and Ocm Ϫ/Ϫ mutant (n ϭ 5) mice to 16 kHz tone bursts given at 80 dB SPL. G, Mean ABR thresholds for adult (14 -26 weeks) Ocm Ϫ/Ϫ mutants (n ϭ 8), Ocm heterozygotes (n ϭ 8), and wild-type mice (n ϭ 4). H, Mean Ϯ SEM DPOAE thresholds as a function of f 2 frequency from the same mice as in G. Small arrows indicate DPOAEs were at the measurement ceiling at which the acoustic system creates its own distortions. I, Mean ABR thresholds in 4-week-old Ocm Ϫ/Ϫ mutants (red filled circles, n ϭ 26) and wild types (black filled squares, n ϭ 14) compared with 12-week-old Ocm Ϫ/Ϫ mutants (red open circles, n ϭ 4) and wild types (black open squares, n ϭ 5). J, Mean Ϯ SEM ABR threshold shifts in 3-month-old mutants (n ϭ 4) and wild types (n ϭ 5) compared with 4-week-old wild types, as in I. K-N, Confocal images of the organ of Corti stained with phalloidin. All images are from the 45 kHz region in Ocm Ϫ/Ϫ mutants (L, N) and wild types (K, M) at 1 and 3 months. Arrows denote missing hair cells. Asterisks denote missing pillar cells. Scale bars, 30 m. O, P, Mean Ϯ SEM hair cell loss at 3 months from wild-type (n ϭ 3) and mutant (n ϭ 3) cochleae. Q, In wild-type controls, prestin (cyan) labels the lateral membrane of OHCs and phalloidin (green) stains actin. R, In Ocm Ϫ/Ϫ mutants (KO) at 3 months, OHCs are shorter and more intensely labeled than in corresponding middle-to-apical regions of the wild-type cochlea. Scale bars: Q, R, 10 m.
and/or prestin, leading to changes in OHC stiffness and subsequently changes to motor function (Frolenkov et al., 2003; Sziklai 2004) . In the present study, the lack of Ocm also leads to abnormal prestin expression. However, this abnormal expression occurs after elevated thresholds were observed. Abnormal prestin expression in Ocm Ϫ/Ϫ mutants again raises the possibility that Ocm and prestin are somehow linked. Indeed, previous reports link Ocm with prestin because both are downregulated by mutations in microRNA-96 that give rise to a progressive hearing loss phenotype (Lewis et al., 2009) . Previous studies have proposed that Ca 2ϩ -based phosphorylation mechanisms affect the gain and magnitude of electromotility (Dulon et al., 1991; Sziklai et al., 2001; Stepanyan and Frolenkov 2009) . Ocm is preferentially localized to the base of the hair bundle and to the basolateral membrane of OHCs (Simmons et al., 2010) , a labeling pattern similar to proteins involved in Ca 2ϩ -dependent processes that affect the motor function of OHCs, such as CaMKIV and prestin. Phosphorylation of both cytoskeletal and prestin proteins is modulated by intracellular Ca 2ϩ . We conclude that Ocm has a distinctive function among endogenous Ca 2ϩ buffers. It is possible that Ocm helps maintain OHC-based electromotility and the long-term survival of OHCs.
